Achillion Pharma (ACHN) Posts Narrower-than-Expected Q3 Loss

November 4, 2014 6:32 AM EST

Achillion Pharma (NASDAQ: ACHN) reported Q3 EPS of ($0.16), $0.02 better than the analyst estimate of ($0.18).

For earnings history and earnings-related data on Achillion Pharma (ACHN) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings